Molecular testing in metastatic basal cell carcinoma

Metastatic basal cell carcinoma (mBCC) is a very rare entity and diagnosis can be challenging. Therapeutic options are limited and response to targeted therapy is poor.

Source: Journal of the American Academy of Dermatology - December 19, 2019 Category: Dermatology Authors: B.J.A. Verkouteren, M. Wakkee, M. van Geel, R. van Doorn, V.J. Winnepenninckx, E. Korpershoek, A.L. Mooyaart, A.K.L. Reyners, J.B. Terra, M.J.B. Aarts, M.G.H.C. Reinders, K. Mosterd Source Type: research